Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

Abstract Background Non-small cell lung cancer (NSCLC) is one of the leading causes of human death worldwide. Herbal prescription SH003 has been developed to treat several cancers including NSCLC. Due to the multi-component nature of SH003 with multiple targets and pathways, a network pharmacology s...

Full description

Bibliographic Details
Main Authors: Kangwook Lee, Yu-Jeong Choi, Hae-In Lim, Kwang Jin Cho, Nuri Kang, Seong-Gyu Ko
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Network pharmacology
Non-small cell lung cancer
SH003
Gene ontology
KEGG
Online Access:https://doi.org/10.1186/s12906-024-04347-y

Internet

https://doi.org/10.1186/s12906-024-04347-y

Similar Items